Combined multiagent chemotherapy and radiotherapy is associated with improved survival compared to chemotherapy alone in patients with non-operatively managed stage II-III pancreatic adenocarcinoma. (2021) - Ocuin, L.M.; Sugumar, K.; Hue, J.J.; Hardacre, J.M.; Ammori, J.B.; Rothermel, L.D.; Dorth, J.; Saltzman, J.; Winter, J.M.